Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance

Diabetic Medicine

Volumn 28, Issue 6, 2011, Pages 699-704

  Laitinen, T ^a,b   Lindstrom J ^c,d   Eriksson, J ^e,f   Ilanne Parikka, P ^g,h   Aunola, S ^c   Keinanen Kiukaanniemi S ^i,j   Tuomilehto, J ^c,d   Uusitupa, M ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h Finnish Diabetes Association   (Finland)

ⁱ UNIVERSITY OF OULU   (Finland)

^j OULU UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

Autonomic nervous system; Autonomic neuropathy; Impaired glucose tolerance

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; AUTONOMIC NEUROPATHY; BODY MASS; BODY WEIGHT; BREATHING EXERCISE; CARDIOVASCULAR AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CENTRAL OBESITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXPIRATION DATE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART BEAT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PARASYMPATHETIC DYSFUNCTION; PARASYMPATHETIC FUNCTION; SYMPATHETIC DYSFUNCTION; SYMPATHETIC FUNCTION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; FINLAND; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OBESITY; PREVALENCE;

EID: 79955947572     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03278.x     Document Type: Article

References (27)

1. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 387-397.
2. Töyry JP, Niskanen LK, Mäntysaari MJ, Länsimies EA, Uusitupa MI. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis. Diabetes 1996; 45: 308-315.
3. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579.
4. Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Lansimies EA, Uusitupa MI et al. Power spectral analysis of heart rate variability during hyperinsulinemia in non-diabetic offspring of type2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes 1999; 48: 1295-1299.
5. Frontoni S, Bracaglia D, Baroni A, Pellegrini F, Perna M, Cicconetti E et al. Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type2 diabetic patients. Hypertension 2003; 41: 1223-1227.
6. Watkins LL, Surwit RS, Grossman P, Sherwood A. Is there a glycemic threshold for impaired autonomic control? Diabetes Care 2000; 23: 826-830.
7. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M et al. Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25: 560-563.
8. Flanagan DE, Vaile JC, Petley GW, Moore VM, Godsland IF, Cockington RA et al. The autonomic control of heart rate and insulin resistance in young adults. J Clin Endocrinol Metab 1999; 84: 1263-1267.
9. Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L. Circadian rhythm of the autonomic nervous system in insulin-resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type2 diabetes mellitus. BMC Cardiovasc Disord 2006; 6: 19.
10. Piccirillo G, Vetta F, Viola E, Santagada E, Ronzoni S, Cacciafesta M et al. Heart rate and blood pressure variability in obese normotensive subjects. Int J Obes Relat Metab Disord 1998; 22: 741-750.
11. Ilanne-Parikka P, Eriksson JG, Lindstrom J, Peltonen M, Aunola S, Hamalainen H et al. Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care 2008; 31: 805-807.
12. Gerritsen J, Dekker JM, TenVoorde BJ, Bertelsmann FW, Kostense PJ, Stehouwer CD et al. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 2000; 43: 561-570.
13. Smulders YM, Jager A, Gerritsen J, Dekker JM, Nijpels G, Heine RJ et al. Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian subjects with impaired glucose tolerance or type2 diabetes: the Hoorn Study. Diabetes Care 2000; 23: 1369-1374.
14. Putz Z, Tabak AG, Toth N, Istenes I, Nemeth N, Gandhi RA et al. Non-invasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009; 32: 181-183.
15. Isak B, Oflazoglu B, Tanridag T, Yitmen I, Us O. Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance. Diabetes Metab Res Rev 2008; 24: 563-569.
16. Eriksson J, Lindstrom J, Valle T, Aunola S, Hamalainen H, Ilanne-Parikka P et al. Prevention of TypeII diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999; 42: 793-801.
17. WHO. Diabetes Mellitus: Report of a WHO Study Group. Technical report series, no. 727. Geneva: World Health Organization, 1985.
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit Pathw Cardiol 2005; 4: 198-203.
19. May O, Arildsen H. Assessing cardiovascular autonomic neuropathy in diabetes mellitus: how many tests to use? J Diabetes Complications 2000; 14: 7-12.
20. Eriksson KF, Nilsson H, Lindgarde F, Osterlin S, Dahlin LB, Lilja B et al. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabet Med 1994; 11: 279-285.
21. Toyry JP, Niskanen LK, Lansimies EA, Partanen KP, Uusitupa MI. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1996; 27: 1316-1318.
22. Freccero C, Svensson H, Bornmyr S, Wollmer P, Sundkvist G. Sympathetic and parasympathetic neuropathy are frequent in both type1 and type2 diabetic patients. Diabetes Care 2004; 27: 2936-2941.
23. Rezende KF, Melo A, Pousada J, Rezende ZF, Santos NL, Gomes I. Neuropatia vegetativa em pacientes com tolerancia diminuida a glicose (Autonomic neuropathy in patients with impaired glucose tolerance). Arq Neuropsiquiatr 1997; 55: 703-711.
24. May O, Arildsen H, Damsgaard EM, Mickley H. Cardiovascular autonomic neuropathy in insulin-dependent diabetes mellitus: prevalence and estimated risk of coronary heart disease in the general population. J Intern Med 2000; 248: 483-491.
25. Liao D, Sloan RP, Cascio WE, Folsom AR, Liese AD, Evans GW et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998; 21: 2116-2122.
26. Stein PK, Barzilay JI, Domitrovich PP, Chaves PM, Gottdiener JS, Heckbert SR et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study. Diabet Med 2007; 24: 855-863.
27. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens 2004; 22: 2363-2369.